A pathogenic in-frame deletion-insertion variant in BEST1 phenocopies Stargardt disease
Authors:
- Masha KolesnikovaMKMasha Kolesnikova
- Jin Kyun OhJOJin Kyun Oh
- Jiali WangJWJiali Wang
- Winston LeeWLWinston Lee
- Jana ZernantJZJana Zernant
- Pei-Yin SuPSPei-Yin Su
- Angela H. KimAKAngela H. Kim
- Laura A. JennyLJLaura A. Jenny
- Tingting YangTYTingting Yang
- Rando AllikmetsRARando Allikmets
- Stephen H. TsangStephen H. Tsang
Open Access
- 8 December 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (23)
Abstract
Here, we describe affected members of a 2-generation family with a Stargardt disease–like phenotype caused by a 2–base pair deletion insertion, c.1014_1015delGAinsCT;p.(Trp338_Asn339delinsCysTyr), in BEST1 . The variant was identified by whole-exome sequencing, and its pathogenicity was verified through chloride channel recording using WT and transfected mutant HEK293 cells. Clinical examination of both patients revealed similar phenotypes at 2 different disease stages that were attributable to differences in their age at presentation. Hyperautofluorescent flecks along the arcades were observed in the proband, while the affected mother exhibited more advanced retinal pigment epithelium (RPE) loss in the central macula. Full-field electroretinogram testing was unremarkable in the daughter; however, moderate attenuation of generalized cone function was detected in the mother. Results from electrooculogram testing in the daughter were consistent with widespread dysfunction of the RPE characteristic of Best disease. Whole-cell patch-clamp recordings revealed a statistically significant decrease in chloride conductance of the mutant compared with WT cells. This report on a mother and daughter with a BEST1 genotype that phenocopies Stargardt disease broadens the clinical spectrum of BEST1 -associated retinopathy.Keywords
Funding Information
- Clinical Center (5P30CA013696, U01 EY030580, U54OD020351, R24EY028758, R24EY027285, 5P30EY019007, R01EY018213, R01EY024698, R01EY026682, R01EY028203, R01EY029315, R21AG050437, GM127652, EY028758)
- Irma T. Hirschl Trust (HRSCHL CU20-4313)
- New York State Stem Cell Science (SDHDOH01-C32590GG-3450000)
- Foundation Fighting Blindness (TA-NMT-0116-0692-COLU, PPA-1218-0751-COLU)
This publication has 41 references indexed in Scilit:
- Predicting the Functional Effect of Amino Acid Substitutions and IndelsPLOS ONE, 2012
- dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictionsHuman Mutation, 2011
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- Suppression of Ca2+ signaling in a mouse model of Best diseaseHuman Molecular Genetics, 2010
- Missense Mutations in a Retinal Pigment Epithelium Protein, Bestrophin-1, Cause Retinitis PigmentosaThe American Journal of Human Genetics, 2009
- Detection of nonneutral substitution rates on mammalian phylogeniesGenome Research, 2009
- Phenotypic Variability Due to a Novel Glu292Lys Variation in Exon 8 of the BEST1 Gene Causing Best Macular DystrophyArchives of Ophthalmology (1950), 2009
- New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophyJournal of Medical Genetics, 2007
- Fundus Autofluorescence Imaging in Best's Vitelliform DystrophyKlinische Monatsblätter für Augenheilkunde, 2003